It has been revealed that CXCL13 demonstrates a lower but still high performance in discriminating between meningitis and meningoencephalitis in comparison to the total lymphocyte and total cell count in the CFS. This evidence concerns the gene CXCL13 and myalgic encephalomeyelitis/chronic fatigue syndrome.